Ultrasound‑targeted microbubble destruction enhances the anti‑tumor action of miR‑4284 inhibitor in non‑small cell lung cancer cells

Tian,Peng; Wang,Yanzhen; Du,Wenyan

doi:10.3892/etm.2021.9983

Ultrasound‑targeted microbubble destruction enhances the anti‑tumor action of miR‑4284 inhibitor in non‑small cell lung cancer cells

Authors:
- Peng Tian
- Yanzhen Wang
- Wenyan Du
View Affiliations

Affiliations: Department of Ultrasonics, Zibo Central Hospital, Zibo, Shandong 255036, P.R. China, Department of Science and Education, Zibo Central Hospital, Zibo, Shandong 255036, P.R. China
Published online on: March 25, 2021 https://doi.org/10.3892/etm.2021.9983
Article Number: 551
Copyright: © Tian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs/miRs) are known to be involved in various human cancer types. Ultrasound‑targeted microbubble destruction (UTMD) may improve the transfection efficiency of exogenous genes into target tissues and organs, thereby improving cancer treatment. In the present study, the role of miR‑4284 in non‑small cell lung cancer (NSCLC) was investigated and the effect of UTMD‑mediated inhibition of miR‑4284 on tumor progression was further analyzed. The expression of miR‑4284 in NSCLC cells and tissues was detected by reverse transcription‑quantitative PCR. UTMD‑mediated inhibition of miR‑4284 was achieved by co‑transfection of microvesicles and miR‑4284 inhibitors into NSCLC cells. A Cell Counting Kit‑8 assay was used to determine NSCLC cell proliferation, and the migration and invasion of NSCLC cells were examined by Transwell assays. Compared with that in the control group, the expression of miR‑4284 was increased in NSCLC tissues and cells. Knockdown of miR‑4284 in NSCLC cells inhibited cell proliferation, migration and invasion. UTMD improved the transfection efficiency of miR‑4284 inhibitors in NSCLC cells, resulting in more significant inhibition of tumor cell proliferation, migration and invasion. In conclusion, the results indicated that the expression of miR‑4284 was increased in clinical samples and cell lines of NSCLC and that knockdown of miR‑4284 inhibited the proliferation, migration and invasion of tumor cells. UTMD‑mediated miR‑4284 inhibition further promoted this effect, indicating that this technique may represent a novel strategy for the treatment of NSCLC.

View Figures

View References

1	Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Brawley OW and Wender RC: Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 68:297–316. 2018.PubMed/NCBI View Article : Google Scholar
2	Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 66:271–289. 2016.PubMed/NCBI View Article : Google Scholar
3	Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, et al: The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 10:1243–1260. 2015.PubMed/NCBI View Article : Google Scholar
4	Cai J, Fang L, Huang Y, Li R, Xu X, Hu Z, Zhang L, Yang Y, Zhu X, Zhang H, et al: Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. Nat Commun. 8(15870)2017.PubMed/NCBI View Article : Google Scholar
5	Chen H and Hwang JH: Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors. J Ther Ultrasound. 1(10)2013.PubMed/NCBI View Article : Google Scholar
6	Tinkov S, Bekeredjian R, Winter G and Coester C: Microbubbles as ultrasound triggered drug carriers. J Pharm Sci. 98:1935–1961. 2009.PubMed/NCBI View Article : Google Scholar
7	Yang H, Sun Y, Wei J, Xu L, Tang Y, Yang L, Zhang X and Lu Y: The effects of ultrasound targeted microbubble destruction (UTMD) carrying IL 8 monoclonal antibody on the inflammatory responses and stability of atherosclerotic plaques. Biomed Pharmacother Oct. 118(109161)2019.PubMed/NCBI View Article : Google Scholar
8	Lee Y, Jeon K, Lee JT, Kim S and Kim VN: MicroRNA maturation: Stepwise processing and subcellular localization. EMBO J. 21:4663–4670. 2002.PubMed/NCBI View Article : Google Scholar
9	Barbato S, Solaini G and Fabbri M: MicroRNAs in Oncogenesis and Tumor Suppression. Int Rev Cell Mol Biol. 333:229–268. 2017.PubMed/NCBI View Article : Google Scholar
10	Dan B, Luo J, Li K and Chen S: Prognostic value of miR-375 for survival outcomes in various cancers: A systematic review and meta-analysis. Oncol Res Treat. 41:47–50. 2018.PubMed/NCBI View Article : Google Scholar
11	Li Y, Shen Z, Jiang H, Lai Z, Wang Z, Jiang K, Ye Y and Wang S: MicroRNA 4284 promotes gastric cancer tumorigenicity by targeting ten-eleven translocation 1. Mol Med Rep. 17:6569–6575. 2018.PubMed/NCBI View Article : Google Scholar
12	Yang F, Nam S, Brown CE, Zhao R, Starr R, Ma Y, Xie J, Horne DA, Malkas LH, Jove R, et al: A novel berbamine derivative inhibits cell viability and induces apoptosis in cancer stem-like cells of human glioblastoma, via up-regulation of miRNA-4284 and JNK/AP-1 signaling. PLoS One. 9(e94443)2014.PubMed/NCBI View Article : Google Scholar
13	Sim J, Kim Y, Kim H, Shin SJ, Kim DH, Paik SS and Jang K: Identification of recurrence-associated microRNAs in stage I lung adenocarcinoma. Medicine (Baltimore). 97(e10996)2018.PubMed/NCBI View Article : Google Scholar
14	Sun W, Zhao P, Zhou Y, Xing C, Zhao L, Li Z and Yuan L: Ultrasound targeted microbubble destruction assisted exosomal delivery of miR-21 protects the heart from chemotherapy associated cardiotoxicity. Biochem Biophys Res Commun. 532:60–67. 2020.PubMed/NCBI View Article : Google Scholar
15	Li X, Xu M, Lv W and Yang X: Ultrasound-targeted microbubble destruction-mediated miR-767 inhibition suppresses tumor progression of non-small cell lung cancer. Exp Ther Med. 19:3391–3397. 2020.PubMed/NCBI View Article : Google Scholar
16	Leong-Poi H, Kuliszewski MA, Lekas M, Sibbald M, Teichert-Kuliszewska K, Klibanov AL, Stewart DJ and Lindner JR: Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ Res. 101:295–303. 2007.PubMed/NCBI View Article : Google Scholar
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
18	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015.PubMed/NCBI View Article : Google Scholar
19	Akhurst T: Staging of non-small-cell lung cancer. PET Clin. 13:1–10. 2018.PubMed/NCBI View Article : Google Scholar
20	Soria JC, Massard C and Le Chevalier T: Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy? Ann Oncol. 21:2324–2332. 2010.PubMed/NCBI View Article : Google Scholar
21	Schwartz AG and Cote ML: Epidemiology of lung cancer. Adv Exp Med Biol. 893:21–41. 2016.PubMed/NCBI View Article : Google Scholar
22	Connell LC, Harding JJ and Abou-Alfa GK: Advanced Hepatocellular Cancer: The Current State of Future Research. Curr Treat Options Oncol. 17(43)2016.PubMed/NCBI View Article : Google Scholar
23	Wang Z, Sha HH and Li HJ: Functions and mechanisms of miR 186 in human cancer. Biomed Pharmacother. 119(109428)2019.PubMed/NCBI View Article : Google Scholar
24	Xue L and Yang D: miR 421 inhibited proliferation and metastasis of colorectal cancer by targeting MTA1. J BUON. 23:1633–1639. 2018.PubMed/NCBI
25	Huang L, Zhang Y, Li Z, Zhao X, Xi Z, Chen H, Shi H, Xin T, Shen R and Wang T: miR-4319 suppresses colorectal cancer progression by targeting ABTB1. United European Gastroenterol J. 7:517–528. 2019.PubMed/NCBI View Article : Google Scholar
26	Yang G, Xiong G, Cao Z, Zheng S, You L, Zhang T and Zhao Y: miR-497 expression, function and clinical application in cancer. Oncotarget. 7:55900–55911. 2016.PubMed/NCBI View Article : Google Scholar
27	Ji Y, Han Z, Shao L and Zhao Y: Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer. Cancer Med. 5:2534–2543. 2016.PubMed/NCBI View Article : Google Scholar
28	Munari E, Marchionni L, Chitre A, Hayashi M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO, et al: Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Hum Pathol. 45:1130–1138. 2014.PubMed/NCBI View Article : Google Scholar
29	Liu W, Wang P, Xie Z, Wang S, Ma M, Li J, Li M, Cen S, Tang S, Zheng G, et al: Abnormal inhibition of osteoclastogenesis by mesenchymal stem cells through the miR-4284/CXCL5 axis in ankylosing spondylitis. Cell Death Dis. 10(188)2019.PubMed/NCBI View Article : Google Scholar
30	Tamaddon G, Geramizadeh B, Karimi MH, Mowla SJ and Abroun S: miR-4284 and miR-4484 as putative biomarkers for diffuse large B-cell lymphoma. Iran J Med Sci. 41:334–339. 2016.PubMed/NCBI
31	Wu J and Li RK: Ultrasound-targeted microbubble destruction in gene therapy: A new tool to cure human diseases. Genes Dis. 4:64–74. 2016.PubMed/NCBI View Article : Google Scholar
32	Shi D, Guo L, Sun X, Shang M, Meng D, Zhou X, Liu X, Zhao Y and Li J: UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis. Sci Rep. 10(6657)2020.PubMed/NCBI View Article : Google Scholar
33	Lin L, Fan Y, Gao F, Jin L, Li D, Sun W, Li F, Qin P, Shi Q, Shi X, et al: UTMD-Promoted Co-Delivery of gemcitabine and miR-21 inhibitor by dendrimer-entrapped gold nanoparticles for pancreatic cancer therapy. Theranostics. 8:1923–1939. 2018.PubMed/NCBI View Article : Google Scholar
34	Yang C, Li B, Yu J, Yang F, Cai K and Chen Z: Ultrasound microbubbles mediated miR-let-7b delivery into CD133⁺ ovarian cancer stem cells. Biosci Rep. 38(38)2018.PubMed/NCBI View Article : Google Scholar